A04AA01 • ondansetron • Alimentary tract and metabolism | Antiemetics and antinauseants | Serotonin (5ht3) antagonists
Ondansetron is a medication used to prevent and treat nausea and vomiting caused by chemotherapy, radiotherapy, or surgery. It belongs to the class of 5-HT3 serotonin receptor antagonists, working by blocking these receptors in the brain and gastrointestinal tract, thereby reducing the reflex of nausea and vomiting.
Ondansetron is administered in the form of tablets, oral solution, or injections, depending on the patient's needs. It is effective in preventing both acute and delayed nausea associated with cancer treatments or postoperative care.
Common side effects include headache, constipation, fatigue, or dizziness. In rare cases, it may cause allergic reactions or heart rhythm disturbances. It is important to use ondansetron as prescribed by a healthcare provider, and patients with heart conditions or those taking other medications should inform their doctor to avoid potential interactions.
Substance: ondansetron
Date of last drug list: 01-03-2021
Commercial code: W67338003
Concentration: 4mg
Pharmaceutical form: injection / infusion solution in pre-filled syringe
Quantity: 10
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: ACCORD HEALTHCARE LIMITED - MAREA BRITANIE
Holder: ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA
Number: 13103/2020/03
Shelf life: 2 years-after packing for marketing;after the first opening-it is used immediately